中駿集團控股(01966.HK)榮獲格隆匯“2019中國上市房企成長潛力獎”
12月12日,由格隆匯主辦的2019“高屋建瓴”房地產高峯論壇在深圳隆重舉行。中駿集團控股(01966.HK)榮獲“2019中國上市房企成長潛力獎”。
本次的主辦方格隆匯是國內領先的投資研究社交平台,擁有超千萬、遍佈全球70多個國家的會員。格隆匯專注為投資者、上市公司、投資機構,提供行情、資訊、研究、交易、數據、社交等一站式海外投融資服務,打造華人投研領先平台。
據主辦方介紹,本次評選覆蓋資本市場已上市的百餘家房地產及相關行業公司,通過“專家評審團審議+大數據分析”的方式,進行綜合評選得出的最終結果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.